SAN ANTONIO — The San Antonio International Airport announced another all-time passenger record for 2024. According to a ...
The European Commission (EC) announced on January 29, 2025, that it launched a Biotech and Biomanufacturing Hub to support ...
The new year marks the transition from the Biden administration and its whole-of-government approach to antitrust enforcement, to the return ...
An Ecuadorean anti-corruption court sentenced eight people to over 17 years in prison and sanctioned three companies for their role in a money laundering scheme linked to ...
European Parliament members this week probed the EU’s new trade commissioner about how he’s handling President Donald Trump’s tariff threats, with some members calling on the EU to prepare for ...
In 2025, regret is the general consensus – and given how little we’ve gained and how much we’ve lost, it’s more than ...
The European medicines regulator said on Friday it will review safety information for Eisai and Biogen's Leqembi, nearly ...
Amgen’s Blincyto (blinatumomab) has been approved by the European Commission (EC) to treat certain acute lymphoblastic ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today an update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab as ...
After the completion of the League Phase of Europe's club competitions this midweek, the Champions League Play-off Draw ...
UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...